PLOD1 and polycystic ovary syndrome: Following intracerebrovascular injection of ALLO into rats, Guiliani et al. (2011) found an increase in LH release [89]; changes in ovarian steroid production and ovarian morphology; decreased follicular development; and reduced ovulation—the same phenotypic profile observed in women with PCOS [90, 91].